| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call to action: time to recognise melioidosis as a neglected tropical disease
|
Savelkoel, Jelmer
|
|
|
22 |
6 |
p. e176-e182
|
artikel
|
| 2 |
Additional considerations for assessing COVID-19 impact on dengue transmission
|
Yek, Christina
|
|
|
22 |
6 |
p. 762-763
|
artikel
|
| 3 |
Additional considerations for assessing COVID-19 impact on dengue transmission – Authors' reply
|
Brady, Oliver J
|
|
|
22 |
6 |
p. 763
|
artikel
|
| 4 |
Amal Saif Al-Maani—fighting antimicrobial resistance
|
Bagcchi, Sanjeet
|
|
|
22 |
6 |
p. 779
|
artikel
|
| 5 |
A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland
|
Lorthe, Elsa
|
|
|
22 |
6 |
p. 767-768
|
artikel
|
| 6 |
Australian floods lead to spread of mosquito-borne disease
|
Nogrady, Bianca
|
|
|
22 |
6 |
p. 771
|
artikel
|
| 7 |
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
|
Arora, Prerna
|
|
|
22 |
6 |
p. 766-767
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2022; 22: 438–40
|
|
|
|
22 |
6 |
p. e159
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2022; published online April 4. https://doi.org/10.1016/S1473-3099(22)00124-4
|
|
|
|
22 |
6 |
p. e159
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2022; published online April 12. https://doi.org/10.1016/S1473-3099(21)00744-1
|
|
|
|
22 |
6 |
p. e159
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2022; published online April 21. https://doi.org/10.1016/S1473-3099(22)00024-X
|
|
|
|
22 |
6 |
p. e159
|
artikel
|
| 12 |
Correction to Lancet Infect Dis 2022; published online March 31. https://doi.org/10.1016/S1473-3099(22)00143-8
|
|
|
|
22 |
6 |
p. e159
|
artikel
|
| 13 |
COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA
|
Krantz, Matthew S
|
|
|
22 |
6 |
p. 747-748
|
artikel
|
| 14 |
Dengue vaccines: where are we now and where we are going?
|
Amorim, Jaime Henrique
|
|
|
22 |
6 |
p. 756-757
|
artikel
|
| 15 |
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
|
Cerqueira-Silva, Thiago
|
|
|
22 |
6 |
p. 791-801
|
artikel
|
| 16 |
Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
|
Garg, Pramod Kumar
|
|
|
22 |
6 |
p. 745-747
|
artikel
|
| 17 |
Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study
|
Radohery, Georges F R
|
|
|
22 |
6 |
p. 760-761
|
artikel
|
| 18 |
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial
|
Evans, Thomas G
|
|
|
22 |
6 |
p. 857-866
|
artikel
|
| 19 |
Explaining the unexplained hepatitis in children
|
The Lancet Infectious Diseases,
|
|
|
22 |
6 |
p. 743
|
artikel
|
| 20 |
Field performance of three Ebola rapid diagnostic tests used during the 2018–20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study
|
Mukadi-Bamuleka, Daniel
|
|
|
22 |
6 |
p. 891-900
|
artikel
|
| 21 |
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
|
Ader, Florence
|
|
|
22 |
6 |
p. 764-765
|
artikel
|
| 22 |
Fluid therapy for severe malaria
|
Kalkman, Laura C
|
|
|
22 |
6 |
p. e160-e170
|
artikel
|
| 23 |
Global evolution and geographic diversity of hypervirulent carbapenem-resistant Klebsiella pneumoniae
|
Wu, Yuye
|
|
|
22 |
6 |
p. 761-762
|
artikel
|
| 24 |
Health-care provision for displaced populations arriving from Ukraine
|
Kamenshchikova, Alena
|
|
|
22 |
6 |
p. 757-759
|
artikel
|
| 25 |
Highlights from ECCMID 2022
|
De Ambrogi, Marco
|
|
|
22 |
6 |
p. 773
|
artikel
|
| 26 |
Humanitarian crisis in Tigray amidst civil war
|
Burki, Talha
|
|
|
22 |
6 |
p. 774-775
|
artikel
|
| 27 |
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9–50 years: a randomised, controlled, phase 2, non-inferiority study
|
Coronel-Martinez, Diana Leticia
|
|
|
22 |
6 |
p. 901-911
|
artikel
|
| 28 |
Implementation of hand hygiene in health-care facilities: results from the WHO Hand Hygiene Self-Assessment Framework global survey 2019
|
de Kraker, Marlieke E A
|
|
|
22 |
6 |
p. 835-844
|
artikel
|
| 29 |
Inequities in access to diagnostics threatens global public health security
|
Fischer 2nd, William A
|
|
|
22 |
6 |
p. 754-756
|
artikel
|
| 30 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
22 |
6 |
p. 775
|
artikel
|
| 31 |
In search of neglect
|
Barksby, Rebecca
|
|
|
22 |
6 |
p. 780
|
artikel
|
| 32 |
Interplay of infection and vaccination in long-term protection from COVID-19
|
Tan, Hyon-Xhi
|
|
|
22 |
6 |
p. 744-745
|
artikel
|
| 33 |
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
|
van der Pluijm, Rob W
|
|
|
22 |
6 |
p. 765-766
|
artikel
|
| 34 |
Johan Hultin
|
Bagcchi, Sanjeet
|
|
|
22 |
6 |
p. 777
|
artikel
|
| 35 |
Mass polio immunisation drive in southern Africa
|
Samarasekera, Udani
|
|
|
22 |
6 |
p. 770
|
artikel
|
| 36 |
Najwa Khuri-Bulos—leading paediatric care in the Arab world
|
Kazi, Farooq
|
|
|
22 |
6 |
p. 778
|
artikel
|
| 37 |
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
|
Sheward, Daniel J
|
|
|
22 |
6 |
p. 813-820
|
artikel
|
| 38 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
6 |
p. 776
|
artikel
|
| 39 |
Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
|
Nordström, Peter
|
|
|
22 |
6 |
p. 781-790
|
artikel
|
| 40 |
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
|
Rosenblum, Hannah G
|
|
|
22 |
6 |
p. 802-812
|
artikel
|
| 41 |
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
|
Barber, Bridget E
|
|
|
22 |
6 |
p. 879-890
|
artikel
|
| 42 |
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21
|
Cohen, Cheryl
|
|
|
22 |
6 |
p. 821-834
|
artikel
|
| 43 |
SARS-CoV-2 transmission: time to rethink public health strategy
|
Parker, Arifa
|
|
|
22 |
6 |
p. 748-750
|
artikel
|
| 44 |
Septic shock with Chlamydia abortus infection
|
Liu, Mengting
|
|
|
22 |
6 |
p. 912
|
artikel
|
| 45 |
SHEA Spring Conference 2022
|
Kazi, Farooq
|
|
|
22 |
6 |
p. 769
|
artikel
|
| 46 |
Spend wisely to eliminate malaria
|
Smithuis, Frank M
|
|
|
22 |
6 |
p. e171-e175
|
artikel
|
| 47 |
The first WHO global survey on infection prevention and control in health-care facilities
|
Tomczyk, Sara
|
|
|
22 |
6 |
p. 845-856
|
artikel
|
| 48 |
The way forward for drug-resistant tuberculosis in the Philippines
|
Bernardo, Madeleine Nicole G
|
|
|
22 |
6 |
p. 760
|
artikel
|
| 49 |
Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance
|
Chen, Ingrid
|
|
|
22 |
6 |
p. 751-753
|
artikel
|
| 50 |
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
|
Peto, Thomas J
|
|
|
22 |
6 |
p. 867-878
|
artikel
|
| 51 |
Universal influenza vaccines are futile when benchmarked against seasonal influenza vaccines
|
Valkenburg, Sophie A
|
|
|
22 |
6 |
p. 750-751
|
artikel
|
| 52 |
Volunteer infection studies accelerate the clinical development of novel drugs against malaria
|
Daubenberger, Claudia
|
|
|
22 |
6 |
p. 753-754
|
artikel
|
| 53 |
WHO's global genomic surveillance strategy
|
Balakrishnan, Vijay Shankar
|
|
|
22 |
6 |
p. 772
|
artikel
|
Tijdschrift beschrijving